Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-995-1 | CAS number: 7783-40-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 08, 2016 - September 22, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- GLP compliance:
- yes
Test material
- Reference substance name:
- Magnesium fluoride
- EC Number:
- 231-995-1
- EC Name:
- Magnesium fluoride
- Cas Number:
- 7783-40-6
- Molecular formula:
- F2Mg
- IUPAC Name:
- magnesium difluoride
- Test material form:
- solid: crystalline
- Details on test material:
- - median particle size 873 um
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Materion / lot 662599-1
- Expiration date of the lot/batch: 31-Jul 2017
- Purity test date: 18- Jan-2016
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: RT, away from moisture
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: low solubility
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: not expected
Test animals / tissue source
- Species:
- other: in vitro study
- Details on test animals or tissues and environmental conditions:
- TEST SYSTEM
- Protocol: In vitro EpiOcularTM eye irritation test (OCL-200-EIT)
- Source: MatTek In Vitro Life Science Laboratories, SR
- Cell line: The EpiOcular™ human cell construct
- Lot: 23735
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 37±1°C
- Cell Culture Conditions: a humidified atmosphere of 5±1% CO2 in air
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL AND CONTROLS
- Amount(s) applied (volume or weight with unit): 50 mg
- Concentration (if solution): as such - Duration of treatment / exposure:
- 6 hours
- Duration of post- treatment incubation (in vitro):
- 18 hours
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- - Details of the test procedure used
The EpiOcularTM cultures were pre-incubated at 37±1°C in a humidified atmosphere of 5±1% CO2 for 60 min. At the end of the first pre-incubation period, the medium was replaced by 1 mL of fresh assay medium. Further, the tissues were pre-incubated in incubator overnight prior to dosing for release of transport stress related compounds and debris. After pre-incubation tissues were pre-wetted with 20 µL of Dulbecco's Phosphate Buffered Saline (DPBS), then 50 µL of control items and 50 mg of the test item were applied topically onto the tissue surface for 6 hours. Two tissues were used per treatment, negative and positive controls. After exposure period, each tissue was rinsed gently with DPBS to remove any residual test item.
- RhCE tissue construct used, including batch number
The EpiOcular™ human cell construct Lot: 23735 was delivered one day before the pre-incubation of tissues and was stored in original package at 2-8°C. At day 1, each culture was removed from the agarose gel using a sterile forceps, inspected and transferred to a pre-labeled 6-well plates containing 1 mL of assay medium per well.
- Doses of test chemical and control substances used
50 mg and 50 µl, respectively
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable)
After post-soak immersion at room temperature, tissues than were transferred to fresh medium and incubated for 18 hours.
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable)
Before testing, test item was checked for its ability to reduce MTT directly. For this purpose, a 1.0 mg/mL MTT solution (in DMEM) was prepared. 50 mg of the test item was added to 1 mL of the MTT solution in a 6-well plate and the mixture was incubated in the dark at 37 +/- 1°C in a humidified atmosphere of 5 +/- 1% CO2 in air (standard culture conditions) for three hours. A negative control (50 μL of aqua pro injectione) was run concurrently. At the end of the exposure time the colour of treated MTT remained unchanged and it was concluded that the test item did not reduce MTT directly.
- Number of tissue replicates used per test chemical and controls (positive control, negative control, NSMTT, NSCliving and NSCkilled, if applicable)
Two
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer)
Spectrophotometer MRX II (Dynex), wavelength 540nm
- Description of the method used to quantify MTT formazan
The MTT assay was performed by transferring the tissues to 24-wells plate containing MTT medium (1 mg/mL) and incubated at 37±1°C in a humidified atmosphere of 5±1% CO2 in air for 3 hours. After incubation, the blue formazan salt formed by cellular mitochondria was extracted with 2 mL/tissue of isopropanol for 2 hours with shaking at room temperature. Each extraction solutions in a volume of 200 μL were transferred to a 96-well plate and the optical density of extracted formazan was determined using a spectrophotometer at 540 nm.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model
60%, established cut-off value (Draft revised TG492, July 2016)
- Positive and negative control means and acceptance ranges based on historical data
Negative Control (NC):
The negative control OD > 1.0 and < 2.6.
Positive Control (PC):
The mean relative viability of the positive control is at 6 hours exposure below 60% of control viability.
- Acceptable variability between tissue replicates for positive and negative controls and for the test chemical
The difference of viability between the two relating tissues of a single chemical is < 20% in the same run
Results and discussion
In vitro
Results
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- The mean tissue viability (%)
- Value:
- 109.1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100.0
- Positive controls validity:
- valid
- Remarks:
- 17.3
- Other effects / acceptance of results:
- OTHER EFFECTS:
not observed
DEMONSTRATION OF TECHNICAL PROFICIENCY:
not demonstrated
ACCEPTANCE OF RESULTS:
Concurrent positive and negative controls were used to ensure adequate performance of the experimental model. Validity of the test method was ascertained by positive control methyl acetate and negative control aqua pro injectione. The tissue viability met the acceptance criterion; mean OD of negative control was 1.172.
The viability of culture treated by positive control methyl acetate was 17,3 %. The positive control met the acceptance criterion: mean tissue viability less than 60%.
- Range of historical values if different from the ones specified in the test guideline:
Any other information on results incl. tables
Test item |
OD |
SD |
Viability |
SD |
in vivo |
|
mean |
of OD |
mean (%) |
of viabilities |
prediction |
Negative controla |
1.172 |
0.033 |
100.0 |
2.77 |
NI |
Positive controlb |
0.203 |
0.020 |
17.3 |
1.66 |
I |
Magnesium Fluoride |
1.279 |
0.010 |
109.1 |
0.81 |
NI |
a H2O
b methyl acetate
Evaluation Criteria
In vitro result In vivo prediction
mean tissue viability ≤ 60% Irritant (I)
mean tissue viability > 60% Non-irritant (NI)
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item Magnesium Fluoride was examined for eye irritation potential in EpiOcularTM Eye Irritation Test (OCL-200-EIT). Based on the results of the study, the test item is considered to be Non-irritant (NI).
- Executive summary:
The test item Magnesium Fluoride was examined for in vitro eye irritation in human model EpiOcularTM. The magnitude of viability was quantified by using MTT test.
Validity of the test method was ascertained by positive control methyl acetate. Two tissue replicates were used for each treatment (exposure time 6 hours), including negative and positive controls. The tissue viability met the acceptance criterion (mean OD of negative control was 1.172). The viability of culture treated by positive control methyl acetate was 17.3%. The positive control met the acceptance criterion: mean tissue viability less than 60%.
Determined viability of culture treated by Magnesium Fluoride (109.1%) fulfilled the criteria for irritancy.
Therefore, the test item Magnesium Fluoride is considered to be non-irritant to the eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.